Bulevirtide vs GHK-Cu
Overview
Bulevirtide is primarily a antiviral peptide, while GHK-Cu is used for healing & recovery.
This page compares Bulevirtide and GHK-Cu across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Bulevirtide | GHK-Cu | |
|---|---|---|
| Category | Antiviral | Healing & Recovery |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | — | 1-3 mg |
| Frequency | — | daily |
| Reported benefits | — | Wound healing, collagen synthesis, anti-inflammatory, antioxidant effects, tissue remodeling |
| Reported side effects | — | Generally safe. Possible: mild skin irritation with topical use |
Key differences
Primary use. Bulevirtide is categorised under Antiviral, while GHK-Cu falls under Healing & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Bulevirtide: FDA-approved. GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Typical dosing for Bulevirtide is not catalogued. GHK-Cu is typically dosed at 1-3 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Bulevirtide and GHK-Cu has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Bulevirtide and GHK-Cu?
- Bulevirtide is primarily a antiviral peptide, while GHK-Cu is used for healing & recovery. Bulevirtide is FDA-approved for one or more indications, whereas GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Bulevirtide used for?
- First/only FDA-approved treatment for chronic hepatitis delta virus (HDV). FDA accelerated approval May 22, 2026. Brand: Hepcludex (Gilead).
- What is GHK-Cu used for?
- Wound healing, skin regeneration.
- Can you take Bulevirtide and GHK-Cu together?
- Some users combine peptides within a single protocol, but stacking Bulevirtide and GHK-Cu has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Bulevirtide or GHK-Cu FDA-approved?
- Bulevirtide is FDA-approved for one or more indications. GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Bulevirtide — full monograph: mechanism, research, dosing & references
- GHK-Cu — full monograph: mechanism, research, dosing & references